metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Most often read
Journal Information

Most often read

131533
COVID-19 and the liver: What do we know after six months of the pandemic?
Nora A. Fierro
Ann Hepatol. 2020;19:590-1
131533
Open access
Open Article
26552
Ocular manifestations of liver disease in children: Clinical aspects and implications
Durga Prasad, Arpita Bhriguvanshi
Ann Hepatol. 2020;19:608-13
26552
Open access
22579
The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease
Daniel Iluz-Freundlich, Manna Zhang, Julia Uhanova, Gerald Y. Minuk
Ann Hepatol. 2020;19:204-8
22579
Open access
14054
The liver in times of COVID-19: What hepatologists should know
Ezequiel Ridruejo, Alejandro Soza
Ann Hepatol. 2020;19:353-8
14054
Open access
Open Article
13612
Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
Stefania Kiapidou, Christina Liava, Maria Kalogirou, Evangelos Akriviadis, Emmanouil Sinakos
Ann Hepatol. 2020;19:134-44
13612
Open access
13448
Bacterial infections in cirrhosis: Current treatment
Godolfino Miranda-Zazueta, Luis A. Ponce de León-Garduño, Jonathan Aguirre-Valadez, Aldo Torre-Delgadillo
Ann Hepatol. 2020;19:238-44
13448
Open access
10065
Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case
Raquel D. Greca, Marlone Cunha-Silva, Larissa B.E. Costa, Júlia G.F. Costa, Daniel F.C. Mazo, Tiago Sevá-Pereira, Marlla M.C. Nascimento, Isadora E. Pereira, ... Jazon R.S. Almeida
Ann Hepatol. 2020;19:107-12
10065
Open access
10047
A systematic review and meta-analysis of the COVID-19 associated liver injury
Yu Jun Wong, Malcolm Tan, Qishi Zheng, James Weiquan Li, Rahul Kumar, Kwong Ming Fock, Eng Kiong Teo, Tiing Leong Ang
Ann Hepatol. 2020;19:627-34
10047
Open access
Open Article
8501
The effect of liver test abnormalities on the prognosis of COVID-19
Alpay Medetalibeyoglu, Yunus Catma, Naci Senkal, Asli Ormeci, Bilger Cavus, Murat Kose, Osman Faruk Bayramlar, Gulcan Yildiz, ... Tufan Tukek
Ann Hepatol. 2020;19:614-21
8501
Open access
Open Article
7623
Mechanisms of kidney dysfunction in the cirrhotic patient: Non-hepatorenal acute-on-chronic kidney damage considerations
María-Jimena Muciño-Bermejo
Ann Hepatol. 2020;19:145-52
7623
Open access
6158
ABCB4 disease: Many faces of one gene deficiency
Eva Sticova, Milan Jirsa
Ann Hepatol. 2020;19:126-33
6158
Open access
5264
Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening?
Diego García-Compeán, Jesús Zacarías Villarreal-Pérez, Manuel Enrique de la O. Cavazos, Fernando Javier Lavalle-Gonzalez, Omar David Borjas-Almaguer, Angel Noé Del Cueto-Aguilera, José Alberto González-González, Consuelo Treviño-Garza, ... Héctor Jesús Maldonado-Garza
Ann Hepatol. 2020;19:258-64
5264
Open access
5178
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies
Alessio Gerussi, Daphne D’Amato, Laura Cristoferi, Sarah Elizabeth O’Donnell, Marco Carbone, Pietro Invernizzi
Ann Hepatol. 2020;19:5-16
5178
Open access
5174
Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis
Angelo A. Mattos, Denusa Wiltgen, Raquel F. Jotz, Caroline M.R. Dornelles, Matheus V. Fernandes, Ângelo Z. Mattos
Ann Hepatol. 2020;19:451-7
5174
Open access
5149
Osteopontin – A potential biomarker of advanced liver disease
Radan Bruha, Libor Vitek, Vaclav Smid
Ann Hepatol. 2020;19:344-52
5149
Open access
5138
SARS-CoV-2 another kind of liver aggressor, how does it do that?
Sonia A. Lozano-Sepulveda, Kame Galan-Huerta, Natalia Martínez-Acuña, Daniel Arellanos-Soto, Ana María Rivas-Estilla
Ann Hepatol. 2020;19:592-6
5138
Open access
Open Article
5084
Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, Giovanni Targher
Ann Hepatol. 2020;19:359-66
5084
Open access
4977
Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population
Rommel Zambrano-Huailla, Laura Guedes, Jose Tadeu Stefano, Arthur A. Arrais de Souza, Sebastián Marciano, Erika Yvamoto, Matheus Truccolo Michalczuk, Denise Siqueira Vanni, ... Claudia P. Oliveira
Ann Hepatol. 2020;19:622-6
4977
Open access
4865
Effects of hepatitis B virus infection, alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase on prediabetes and diabetes mellitus: A cohort study
Ting Gan, Ning Cheng, Jiao Ding, Zhiyuan Cheng, Desheng Zhang, Haiyan Li, Juansheng Li, Na Li, ... Yana Bai
Ann Hepatol. 2020;19:197-203
4865
Open access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos